Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus

Lancet

Volumn 347, Issue 8994, 1996, Pages 92-93

  Vento, Sandro ^a   Cainelli, Francesca ^a   Mirandola, Franca ^a   Cosco, Lucio ^b   Di Perri, Giovanni ^a   Solbiati, Maurizio ^a   Ferraro, Teresa ^b   Concia, Ercole ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b PUGLIESE CIACCIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; VINBLASTINE; VINCRISTINE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CHRONIC HEPATITIS; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LYMPHOMA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VIRUS REACTIVATION;

EID: 0030067985     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90212-3     Document Type: Article

References (12)

1. Bird GLA, Smith H, Portmann B, Alexander GJM, Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med 1989; 73: 895-902.
2. Wright TL, Hsu H, Donegan E, et al. Hepatitis C virus not found in fulminant non-A, non-B hepatitis. Ann Intern Med 1991; 115: 111-12.
3. Dienes HP, Popper H, Arnold W, Lobeck H. Histologic observations in human hepatitis non-A, non-B. Hepatology 1982; 2: 562-71.
4. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-99.
5. Cristiano K, Di Bisceglie AM, Hoofnagle JH, Feinstone SM. Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. Hepatology 1991; 14: 51-55.
6. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74: 2391-99.
7. Urdea MS, Horn T, Fultz TJ, et al. Branched DNA amplification multimers for the sensitive, direct detection of human hepatitis viruses. Nucl Acids Res 1991; 24: 197-200.
8. Manzini P, Saracco G, Cerchier A, et al. Human immunodeficiency virus infection as risk factor for mother-to-child hepatitis C virus transmission: persistence of anti-hepatitis C virus in children is associated with the mother's anti-hepatitis C virus immunoblotting pattern. Hepatology 1995; 21: 328-32.
9. Chomczinsky P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-59.
10. Kwok S, Higuchi R. Avoiding false positive with PCR. Nature 1989; 339: 237-38.
11. Cock KMD, Govindarajan S, Valinluck B, Redeker AG. Hepatitis B virus DNA in fulminant hepatitis B. Ann Intern Med 1986; 105: 546-47.
12. Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transpl 1991; 8: 417-20.